Chemed Corp (NYSE:CHE)

paek813 (96.67) Submitted: 5/20/2013 12:38:22 PM : Start Price: $68.90 CHE Score: +0.24

S&P Fair Value Rank 5   

S&P Earnings & Dividend Rank A   

Relative Strength (RSI) 12   

ROE 20.6%

ROE 2Yrs. Ago 19.6%
______________________________________

- This company provides hospice services for patients with severe, life-limiting illnesses;

- and also provides plumbing and drain cleaning services.
______________________________________

May 3, 2013:

US Dept. of Justice says US has filed suit against CHE and various wholly owned hospice subsidiaries, including Vitas Hospice Services LLC and Vitas Healthcare Corporation, alleging false Medicare billings for hospice services.

April 19, 2013:

Chemed Corp. announced unaudited consolidated financial results for the first quarter ended March 31, 2013. For the quarter, the company reported service revenues and sales of $366.641 million against $352.943 million a year ago. Income from operations was $38.852 million against $34.977 million a year ago. Income before income taxes was $36.464 million against $33.455 million a year ago. Net income was $22.278 million or $1.17 per diluted share against $20.445 million or $1.06 per diluted share a year ago. Net cash provided by operating activities was $8.141 million against $10.381 million a year ago. Capital expenditures were $5.406 million against $12.018 million a year ago. Adjusted EBITDA was $51.296 million against $46.340 million a year ago. Adjusted net income was $26.140 million or $1.38 per diluted share against $23.340 million or $1.21 per diluted share a year ago. The management reaffirms previous guidance that full-year 2013 earnings per diluted share, excluding non-cash expense for stock options, the non-cash interest expense related to the accounting for convertible debt and other items not indicative of ongoing operations, will be in the range of $5.65 to $5.80. This compares to Chemed's 2012 reported adjusted earnings per diluted share of $5.29.

xserver (98.55) Submitted: 5/18/2013 6:12:24 PM : Start Price: $68.25 CHE Score: -0.91

Citron Research:
Nation’s largest hospice provider (74% of revenues). Medicare pays for 90%. On May 2, the US Department of Justice filed a false claims act lawsuit alleging fraudulent billing in 20 states. On May 6 the Department of Justice joined a second suit by Dr Charles Gonzales charging Chemed of “enrolling patients in hospice who are not in fact at end-of-life, then billing and collecting for services not provided, or services provided to patients who don’t need them and don’t qualify for them. Enrolling hospice patients in “critical care” categories, allowing them to bill dramatically larger daily amounts based on falsified patient categorizations.”

2trpop (83.88) Submitted: 1/29/2013 12:40:21 PM : Start Price: $75.22 CHE Score: -19.12

fstg experiment

GMoneyCaps (89.25) Submitted: 12/13/2011 8:50:05 PM : Start Price: $47.34 CHE Score: +9.32

12/13

PaulNy (96.03) Submitted: 12/7/2009 1:01:56 PM : Start Price: $45.56 CHE Score: +1.35

Pretty nice return on equity and assets; seems to be fairly solid slow growing company.

madmuffin (49.95) Submitted: 10/21/2009 4:15:32 PM : Start Price: $44.91 CHE Score: -0.77

great fundamentals

mungovan48 (96.52) Submitted: 4/21/2009 5:39:33 PM : Start Price: $40.31 CHE Score: -28.79

Good company. Growth industry (healthcare) and anti-cyclical industry (plumbing).

WilliamCrook2007 (< 20) Submitted: 11/20/2008 3:08:15 PM : Start Price: $36.59 CHE Score: -29.13

IBD

PennyStockFool (30.90) Submitted: 11/6/2008 11:38:49 AM : Start Price: $41.68 CHE Score: +20.32

Chart looks like it might hit a brick wall and turn back south here!!

greygoose100 (< 20) Submitted: 9/22/2008 3:46:59 PM : Start Price: $42.01 CHE Score: +22.06

good nat gas ,supply and pipeline distribution

DorMill (51.18) Submitted: 7/1/2008 6:48:33 PM : Start Price: $35.47 CHE Score: -60.18

Slow and steady wins the race. This stock creeps up bits at a time but you know, people still need their Roto Roter in good times and bad.

C4M1 (72.34) Submitted: 5/6/2008 4:56:43 PM : Start Price: $32.48 CHE Score: +89.44

People are going to continue using this service, but i think a slow down will occur first as people try and fix things themselves. their medical side of the company should continue to do well though I would think.